Seeing Is Believing
Currently, out of the existing stock ratings of Jessica Fye - 76 which are a Hold (36.19%), 14 which are a Sell (6.67%), 120 which are a Buy (57.14%)
Analyst Jessica Fye works at JPMORGAN and is covering the Healthcare sector with 401 price targets and ratings displayed on 42 stocks.
Jessica Fye's average stock forecast success ratio is 80.28% with an average time for price targets to be met of 189.05 days.
Most recent stock forecast was given on IMCR, at 13-Sep-2023.
Analyst best performing recommendations are on APRE (APREA THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 5/3/2018. The price target of $41 was fulfilled within 1 day with a profit of $4.07 (11.02%) receiving and performance score of 110.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
1
$0.08 (8.70%)
5
2 months 10 days ago
8/9 (88.89%)
$0.6 (18.39%)
57
Buy
3
$2.08 (226.09%)
5
8 months 24 days ago
4/16 (25%)
$8.22 (56.00%)
71
Sell
1 years 3 months 24 days ago
2/4 (50%)
$4.78 (37.42%)
1444
Hold
19
$18.08 (1965.22%)
19
1 years 10 months 27 days ago
0/23 (0%)
$14.53 (233.04%)
Buy
16
$15.08 (1639.13%)
12
2 years 7 months 29 days ago
0/6 (0%)
$6.74 (91.65%)
Which stock is Jessica Fye is most bullish on?
Which stock is Jessica Fye is most reserved on?
What Year was the first public recommendation made by Jessica Fye?